What is the 'average' TRT dose, and does it matter for you?
Quick answer
The creator promotes starting testosterone cypionate doses of 90-150mg weekly through their clinic, with a three-month blood test follow-up. While 90-100mg weekly aligns with Endocrine Society guidelines for initiating therapy, 150mg weekly as a universal starting dose exceeds what most guidelines recommend before baseline labs are reviewed. The follow-up bloodwork timeline cited is accurate and consistent with standard clinical monitoring protocols.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @kmartfit actually say?
The creator, posting on behalf of Harley Meds, told viewers that "most men are getting started on anywhere between about 90 milligrams" up to "150 per week" of testosterone. They also said patients get a follow-up blood test three months in to confirm levels are in an "optimized range." The video ends with a call to switch clinics.
To be clear about what this is: this is a paid promotional video for a telehealth TRT clinic, not independent health education. The creator is actively recruiting patients with a comment-trigger funnel. That context matters when evaluating every claim made here.
Does the science back this up?
Partially. The 90-150mg weekly range is within real-world clinical practice, but framing it as a universal starting point glosses over significant individual variability and established guideline recommendations that often start lower.
The Endocrine Society's 2018 clinical practice guidelines recommend testosterone therapy be initiated at doses that bring serum testosterone into the mid-normal range, typically 400-700 ng/dL, without specifying a single milligram target. A 2020 review by Bhasin et al. in the New England Journal of Medicine noted that standard injectable testosterone cypionate or enanthate dosing typically ranges from 75-100mg weekly or 150-200mg every two weeks, with titration based on trough levels. So 90mg weekly is reasonable. But 150mg weekly as a starting dose is on the higher end and could push some men, particularly those with higher baseline sensitivity, into supraphysiologic ranges before any bloodwork has been reviewed.
The three-month follow-up bloodwork claim is consistent with Endocrine Society guidance, which recommends checking testosterone levels 3-6 months after initiating therapy.
What did they get wrong (or right)?
They got the general dosing ballpark mostly right, but the framing is sloppy in ways that matter clinically. Starting at 150mg weekly without first assessing baseline testosterone, hematocrit, PSA, or cardiovascular risk is not best practice. It is a number chosen for convenience, not precision.
The phrase "optimized range" is also doing a lot of work here without definition. "Optimized" is not a clinical term. The Endocrine Society talks about physiologic replacement, meaning restoring levels to what is normal for a healthy young adult male, not maximizing them. Clinics that use "optimized" language often target the upper-normal or even supraphysiologic range, which carries real risks: erythrocytosis, elevated hematocrit, cardiovascular strain, and suppressed fertility. A 2023 study by Lincoff et al. in NEJM (the TRAVERSE trial) found that testosterone therapy in men with hypogonadism did not increase major cardiovascular events compared to placebo, but that finding applies to physiologic replacement, not aggressive optimization.
The three-month blood test timeline is genuinely correct and worth acknowledging. That is standard, evidence-based follow-up practice.
What should you actually know?
TRT dosing is not one-size-fits-all, and any clinic that tells you otherwise before seeing your bloodwork should raise a flag. Starting dose should be based on your baseline testosterone level, your symptoms, your age, your hematocrit, and your cardiovascular history, not a standard intake protocol.
Injectable testosterone cypionate and enanthate are the most studied forms of TRT. Weekly dosing of 75-100mg is a common and well-supported starting point for most men, with upward titration only after confirming trough levels. Jumping to 150mg weekly from day one is aggressive and not universally appropriate.
The "optimized" framing used by many direct-to-consumer TRT clinics is a marketing term, not a medical one. Ask your provider what specific serum testosterone level they are targeting and why. A provider who cannot answer that question clearly is not practicing evidence-based medicine. If you are considering TRT, work with a provider who reviews your full labs, not just your total testosterone, before writing any prescription.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For What is the 'average' TRT dose, and does it matter for you?, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
What is the 'average' TRT dose, and does it matter for you? is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
The creator promotes starting testosterone cypionate doses of 90-150mg weekly through their clinic, with a three-month blood test follow-up.
FormBlends verdict
The creator promotes starting testosterone cypionate doses of 90-150mg weekly through their clinic, with a three-month blood test follow-up. While 90-100mg weekly aligns with Endocrine Society guidelines for initiating therapy, 150mg weekly as a universal starting dose exceeds what most guidelines recommend before baseline labs are reviewed. The follow-up bloodwork timeline cited is accurate and consistent with standard clinical monitoring protocols.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator promotes starting testosterone cypionate doses of 90-150mg weekly through their clinic, with a three-month blood test follow-up. While 90-100mg weekly aligns with Endocrine Society guidelines for initiating therapy, 150mg weekly as a universal starting dose exceeds what most guidelines recommend before baseline labs are reviewed. The follow-up bloodwork timeline cited is accurate and consistent with standard clinical monitoring protocols.
- Endocrine Society 2018 guidelines recommend starting testosterone at doses that achieve mid-normal serum levels (roughly 400-700 ng/dL), with no single universal milligram target.
- 75-100mg of testosterone cypionate or enanthate weekly is the most commonly cited evidence-based starting dose per Bhasin et al., 2020, NEJM. 150mg weekly as a first dose is aggressive.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Endocrine Society 2018 guidelines recommend starting testosterone at doses that achieve mid-normal serum levels (roughly 400-700 ng/dL), with no single universal milligram target.
- 75-100mg of testosterone cypionate or enanthate weekly is the most commonly cited evidence-based starting dose per Bhasin et al., 2020, NEJM. 150mg weekly as a first dose is aggressive.
- Three-month follow-up bloodwork is accurate and aligns with clinical monitoring standards. Any TRT provider not doing this is falling short of basic care.
- The TRAVERSE trial (Lincoff et al., 2023, NEJM) found testosterone therapy did not significantly increase major cardiovascular events in hypogonadal men, but this applies to physiologic replacement, not high-dose optimization protocols.
- "Optimized" is not a clinical term. Ask any TRT provider to name a specific target serum testosterone level and explain the evidence behind it before starting therapy.
- Before any TRT dose is prescribed, baseline labs should include total and free testosterone, hematocrit, PSA, LH, FSH, and a metabolic panel. A clinic that skips this step is cutting corners.
- Supraphysiologic testosterone levels increase the risk of erythrocytosis (elevated red blood cell mass), which raises clotting risk. Hematocrit monitoring is not optional.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
KMART · TikTok creator
9.7K views on this video
Average dose of testosterone
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by KMART, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.